Economic burden of mucormycosis in the United States: can a vaccine be cost-effective?

Author: Ibrahim Ashraf   Edwards John   Bryant Richard   Spellberg Brad  

Publisher: Informa Healthcare

ISSN: 1460-2709

Source: Medical Mycology, Vol.47, Iss.6, 2009-08, pp. : 592-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content